First Patients in U.S. Treated with Distalmotion’s Dexter Surgical Robot in the Outpatient Setting

October 28 , 2024 Distalmotion’s Dexter Surgical Robot opens an entire new era for soft tissue robotics in the outpatient setting and ambulatory surgery centers that will have immediate benefit for patients. ​​​ ​​​Distalmotion has been granted De Novo approval by the U.S. Food and Drug Administration (FDA) to market the Dexter Surgical Robot for … Read more

FDA Grants De Novo Marketing Authorization for the Distalmotion Dexter® Surgical Robot

October 28 , 2024 Distalmotion, a pioneer in surgical robotics, proudly announces the achievement of a significant milestone: surpassing 1000 successful procedures with its surgical robot, Dexter. Since its first commercial installation in 2022, Dexter has become a cornerstone in surgical innovation, treating patients everyday across multiple countries and institutions. ​​​ Distalmotion has been granted … Read more

Distalmotion Celebrates Milestone: Over 1000 Procedures Successfully Completed with the Surgical Robot Dexter®

May 15 , 2024 Distalmotion, a pioneer in surgical robotics, proudly announces the achievement of a significant milestone: surpassing 1000 successful procedures with its surgical robot, Dexter. Since its first commercial installation in 2022, Dexter has become a cornerstone in surgical innovation, treating patients everyday across multiple countries and institutions. This milestone underscores the maturity … Read more

With Proximie to Extend Surgical Excellence Globally

January 10, 2024 Distalmotion – a pioneer in surgical robotics, is partnering with Proximie, the leading global health technology platform digitizing operating rooms (ORs), to extend its ground-breaking Dexter® robotic surgery platform globally. The collaboration provides Distalmotion customers with access to Proximie’s healthcare platform, delivering telepresence, content management, and data driven insights. With Proximie, surgeon … Read more